414 related items for PubMed ID: 3147413
1. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
Maher ER, Sweny P, Chappel M, Varghese Z, Moorhead JF.
Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
[Abstract] [Full Text] [Related]
2. Long-term treatment of minimal-change nephrotic syndrome with cyclosporin: a control biopsy study.
Clasen W, Kindler J, Mihatsch MJ, Sieberth HG.
Nephrol Dial Transplant; 1988; 3(6):733-7. PubMed ID: 3147414
[Abstract] [Full Text] [Related]
3. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[Abstract] [Full Text] [Related]
4. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
Hamed RM.
J Nephrol; 1997 Jul; 10(5):266-70. PubMed ID: 9364319
[Abstract] [Full Text] [Related]
5. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ.
Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
[Abstract] [Full Text] [Related]
6. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
7. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D'Agati V, Appel G.
Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
[Abstract] [Full Text] [Related]
8. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
Li X, Li H, Chen J, He Q, Lv R, Lin W, Li Q, He X, Qu L, Suya W.
Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
[Abstract] [Full Text] [Related]
9. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
Muso E, Yashiro M, Matsushima M, Yoshida H, Sawanishi K, Sasayama S.
Nephrol Dial Transplant; 1994 Jun; 9(3):257-64. PubMed ID: 8052431
[Abstract] [Full Text] [Related]
10. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P.
Nephrol Dial Transplant; 1993 Jun; 8(12):1326-32. PubMed ID: 8159300
[Abstract] [Full Text] [Related]
11. Cyclosporine in idiopathic nephrotic syndrome.
Ponticelli C.
Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
[Abstract] [Full Text] [Related]
12. Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome.
Clin Nephrol; 1991 Aug; 35 Suppl 1():S48-60. PubMed ID: 1860268
[Abstract] [Full Text] [Related]
13. Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome.
Kashtan C, Melvin T, Kim Y.
Clin Nephrol; 1988 Feb; 29(2):79-85. PubMed ID: 3359697
[Abstract] [Full Text] [Related]
14. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M.
Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
[Abstract] [Full Text] [Related]
15. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
Sinha MD, MacLeod R, Rigby E, Clark AG.
Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
[Abstract] [Full Text] [Related]
16. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
Hafeez F, Ahmad TM, Anwar S.
J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
[Abstract] [Full Text] [Related]
17. Cyclophosphamide alone in the treatment of adult patients with minimal change glomerulonephritis.
Al-Khader AA, Lien JW, Aber GM.
Clin Nephrol; 1979 Jan; 11(1):26-30. PubMed ID: 428152
[Abstract] [Full Text] [Related]
18. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults.
Matsumoto H, Nakao T, Okada T, Nagaoka Y, Shino T, Yoshino M, Hidaka H.
Clin Nephrol; 2001 Feb; 55(2):143-8. PubMed ID: 11269678
[Abstract] [Full Text] [Related]
19. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis.
Windom HH, Fisher M, Neale TJ.
N Z Med J; 1990 Mar 28; 103(886):125-6. PubMed ID: 2320338
[Abstract] [Full Text] [Related]
20. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
Opastirakul S, Chartapisak W.
J Med Assoc Thai; 2006 Dec 28; 89(12):2145-9. PubMed ID: 17214070
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
